Aquarius Surgical Technologies AI Stock Analysis
Want to see TSE:ASTI full AI Analyst Report?
Aquarius Surgical Technologies (ASTI) AI Stock Analysis
Aquarius Surgical Technologies
(CNQX:ASTI)
The score is driven primarily by severe financial weakness, including negative equity, excessive leverage, persistent losses, and cash burn. Technical conditions provide limited support because positive MACD is outweighed by overbought momentum and a close below all stated moving averages. The negative P/E and absent dividend yield further constrain the valuation.
Aquarius Surgical Technologies (ASTI) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 115.92K
- Dividend Yield
- ―
- Average Volume (3M)
- 37.59K
- Price to Earnings (P/E)
- -0.2
- Beta (1Y)
- -0.32
- Revenue Growth
- 8.66%
- EPS Growth
- -545.88%
- Country
- Canada
- Employees
- 3
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Aquarius Surgical Technologies Business Overview & Revenue Model
Company Description
Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings through...
Aquarius Surgical Technologies Financial Statement Overview
Summary
The financial profile is extremely weak: the provided income statement, balance sheet, and cash flow scores are 22, 9, and 18, respectively. Large losses, debt exceeding assets, deeply negative equity, and recurring cash burn justify the minimum component score.
Income Statement
22NegativeBalance Sheet
9Very NegativeCash Flow
18Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2023 | Mar 2022 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.44K | 91.44K | 91.20K | 205.25K | 327.66K | 958.74K |
| Gross Profit | 40.16K | 33.48K | 47.31K | 132.85K | 130.30K | 378.25K |
| EBITDA | 655.51K | -241.88K | -832.81K | -456.62K | -611.35K | -1.18M |
| Net Income | -651.71K | -651.71K | -1.17M | -757.66K | -859.20K | -1.61M |
Balance Sheet | ||||||
| Total Assets | 1.91M | 1.91M | 1.95M | 574.44K | 894.98K | 1.66M |
| Cash, Cash Equivalents and Short-Term Investments | 44.51K | 44.51K | 7,559 | 107.38K | 158.19K | 105.19K |
| Total Debt | 6.94M | 6.94M | 6.47M | 4.04M | 3.24M | 2.02M |
| Total Liabilities | 8.34M | 8.34M | 7.72M | 5.18M | 4.11M | 2.35M |
| Stockholders Equity | -6.42M | -6.42M | -5.77M | -4.61M | -3.21M | -689.15K |
Cash Flow | ||||||
| Free Cash Flow | -116.36K | -116.36K | -383.29K | -256.92K | -117.38K | -1.07M |
| Operating Cash Flow | -116.36K | -116.36K | -383.29K | -252.56K | -112.16K | -951.17K |
| Investing Cash Flow | 0 | 0 | -1.80M | -4,358 | -5,221 | -86.99K |
| Financing Cash Flow | 153.31K | 153.31K | 2.08M | 242.29K | 129.59K | 1.02M |
Aquarius Surgical Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 28.78 is Positive, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ASTI.
Aquarius Surgical Technologies Peers Comparison
Overall Rating
TSE:PRN53Neutral
TSE:PINK44Neutral
TSE:ASG43Neutral- TSE:ASTI40Underperform
TSE:VPT37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:PRN | 53Neutral | CAD 409.49M | -8.04 | -59.18% | ― | 64.70% | 30.61% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:PINK | 44Neutral | CAD 22.25M | -1.15 | -303.05% | ― | 35.27% | 58.34% |
| TSE:ASG | 43Neutral | CAD 7.81M | -4.55 | -34.32% | ― | -5.42% | -5.37% |
| TSE:ASTI | 40Underperform | CAD 275.99K | -0.18 | 23.95% | ― | 8.66% | -545.88% |
| TSE:VPT | 37Underperform | CAD 14.47M | -5.36 | 56.40% | ― | 89.06% | 37.62% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:ASTI | Aquarius Surgical Technologies | 0.01 | 0.00 | 0.00% | |
| TSE:ASG | Aurora Spine | 0.10 | -0.21 | -67.74% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.15 | -0.04 | -21.05% | |
| TSE:PRN | Profound Medical | 10.53 | 1.11 | 11.78% | |
| TSE:VPT | VentriPoint Diagnostics | 0.07 | -0.03 | -30.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026